2023 Classic Lectures in PET/CT Imaging – A CME Teaching Activity
CategoriesRadiology, Nuclear Medicine, Oncology, Radiation Oncology
Release Date October 15 2023
This CME activity brings together some of our most popular lectures in PET and PET/CT imaging. Basic to advanced applications of PET and PET/CT are put in the context of disease detection and treatment planning. Faculty share techniques, tips and pitfalls through case-based presentations.
This CME activity should benefit radiologists, oncologists, and nuclear medicine physicians. The course should also prove valuable for physicians who order these studies.
Topics under this Course
|
|
| Erik S. Mittra, M.D., Ph.D. | |
| PET/CT Neurodegenerative Diseases | |
| Gagandeep Choudhary, M.D. | |
| PET/CT in Coronary Disease and Cardiac Sarcoidosis | |
| Mark I. Travin, M.D. | |
| PET/CT for Non-Neurodegenerative Diseases | |
| Gagandeep Choudhary, M.D. | |
| PET/CT in Head and Neck Cancer | |
| Don C. Yoo, M.D. | |
| PET/CT in Thyroid Cancer | |
| Mark Tulchinsky, M.D., FACNM | |
| PET/CT in Lung Cancer | |
| Don C. Yoo, M.D. | |
| PET/CT in Malignancy of the Breast and Female Pelvis | |
| Katherine Zukotynski, M.D. | |
| Qualitative and Quantitative Response Criteria | |
| Erik S. Mittra, M.D., Ph.D. | |
| PET/CT in Infection and Inflammation Imaging | |
| Don C. Yoo, M.D. | |
| PET/CT in Theragnostics | |
| Erik S. Mittra, M.D., Ph.D. | |
| Ga-68 and Lu-177 DOTATATE in Neuroendocrine Tumors | |
| Katherine Zukotynski, M.D. | |
| PET/CT in Lymphomas | |
| Mark Tulchinsky, M.D., FACNM | |
| PET/CT in Prostate Cancer | |
| Erik S. Mittra, M.D., Ph.D. | |
| PET/CT in Skeletal Tumors: Primary and Metastatic | |
| Katherine Zukotynski, M.D. | |
| PET/CT in Cancers of the Skin | |
| Mark Tulchinsky, M.D., FACNM | |
| PET – Tumor and Whole Body Imaging | |
| Edwin L. Palmer, M.D. | |
| Endocrine Radionuclide Imaging | |
| Carl K. Hoh, M.D. | |
| CNS Radionuclide Imaging | |
| Carl K. Hoh, M.D. | |
| Cardiovascular Radionuclide Imaging | |
| Edwin L. Palmer, M.D. |



